Edoxaban API

Name	Edoxaban
Chinese name	依度沙班
Cas Number	912273-65-5
Source	India
Qualifications	USDMF/-/-/-/-

The original research was Daiichi Sankyo Pharmaceutical, which was approved by the FDA for marketing in 2015. Edoxaban is a small molecule oral anticoagulant. It is a coagulation factor X (FXa) blocker. It is the fourth new oral anticoagulant approved by the FDA after dabigatran, rivaroxaban and apixaban. Coagulant (NOAC). This product achieves the purpose of inhibiting thrombosis by selectively, reversibly and directly inhibiting coagulation factor X (FXa). Clinical studies have verified its good tolerability, oral absorption and anticoagulant activity, and it is used to prevent patients with atrial fibrillation The effect of stroke and systemic embolization is good, and the bleeding is less than enoxaparin-warfarin treatment. Direct FXa inhibitors are the development trend of anticoagulant drugs. With the aging of the population and the increasing incidence of cardiovascular diseases, the demand for anticoagulant drugs is increasing. It is believed that these drugs will benefit more patients.

Hot Tags: edoxaban api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Escitalopram Oxalate API, Tippyridine Hydrochloride API, Valganciclovir Hydrochloride API, Active Pharmaceutical Ingredient, Aprepitant Aprepitant API, Salmeterol Xinafoate API

• Previous: Pabxilib API
• Next: Idebenone API